Studies are now being pursued to ability the of implantable bioelectric device stimulation of the vagal nerve to attenuate disease activity in patients with rheumatoid arthritis. The rationale is to upregulate the parasympathetic nervous system with vagal stimulation and simultaneously downgrade the sympathetic predominance that is associated with increased disease activity in rheumatoid arthritis.